ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ACIN1 | Apoptotic chromatin condensation inducer 1 | Plasma proteins Transporters
| | | | | Expressed in all |
ASNA1 | ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | Transporters
| | | | | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP4B | ATPase, H+/K+ exchanging, beta polypeptide | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Transporters
| | | | | Expressed in all |
ATP6V1C1 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 | Transporters
| | | | | Expressed in all |
ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | Plasma proteins Transporters
| | | | | Expressed in all |
ATP6V1F | ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F | Transporters
| | | | | Expressed in all |
ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 | Plasma proteins Transporters
| | | | | Expressed in all |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Transporters
| | | | | Tissue enriched |
ATP6V1H | ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H | Transporters
| | | | | Expressed in all |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
COX4I1 | Cytochrome c oxidase subunit IV isoform 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
COX5A | Cytochrome c oxidase subunit Va | Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
COX5B | Cytochrome c oxidase subunit Vb | Mitochondrial proteins Transporters
| | | | | Expressed in all |
COX7C | Cytochrome c oxidase subunit VIIc | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
DERL1 | Derlin 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
EIF4A3 | Eukaryotic translation initiation factor 4A3 | Disease related genes Enzymes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
GLE1 | GLE1 RNA export mediator | Disease related genes Potential drug targets Transporters
| | | | | Expressed in all |
MAGOH | Mago-nashi homolog, proliferation-associated (Drosophila) | Transporters
| | | | | Expressed in all |